TY  -  JOUR
AU  -  Liang, Yiwi
AU  -  Feng, Mengyun
AU  -  Yang, Ruolan
AU  -  Gou, Jiayi
AU  -  Wang, Mengyu
AU  -  Zhao, Jinzhen
AU  -  Pan, Xianqi
AU  -  Li, Jian
AU  -  Han, Qui
T1  -  Effects of long-term remote ischemic preconditioning on exercise performance in athletes: a systematic review and meta-analysis
PY  -  2026
Y1  -  2026-07-01
DO  -  10.1728/4812.48403
JO  -  Medicina dello Sport
JA  -  Med Sport
VL  -  79
IS  -  3
SP  -  154
EP  -  173
PB  -  Il Pensiero Scientifico Editore
SN  -  1827-1863
Y2  -  2026/11/19
UR  -  http://dx.doi.org/10.1728/4812.48403
N2  -  Summary. Background. Due to its ease of operation, non-invasive nature, and low cost, ischemic preconditioning (IPC) has been widely adopted in sports as an auxiliary tool for enhancing athletic performance. This study performed a systematic review and meta-analysis of randomized controlled trials to evaluate the effects of long-term IPC on athletes’ performance. Method. The meta-analysis was conducted in accordance with the PRISMA guidelines, and figures were generated using Review Manager 5.4 software. Relevant keywords such as “ischemic preconditioning”, “remote ischemic preconditioning”, “exercise performance”, and “athlete”, were used to search the CNKI, Wanfang Data, VIP, PubMed, Embase, Web of Science, and Cochrane Library databases. The search included both Chinese and English language literature from database inception to April 18, 2026. Primary outcomes were sports performance (completion time, CT), aerobic endurance (peak oxygen uptake, VO₂ peak), and anaerobic power output (mean power output, MPO; peak power output, PPO; fatigue index, FI%). Secondary outcomes included metabolic stress (blood lactate, BLa), muscle damage and inflammatory markers (creatine kinase, CK; C-reactive protein, CRP; white blood cell count, WBC), cardiovascular responses (systolic blood pressure, SBP; diastolic blood pressure, DBP; heart rate, HR), rating of perceived exertion (RPE), and erythrocyte system parameters (red blood cell count, RBC; hemoglobin, Hb; red blood cell distribution width, RDW). Effect sizes were pooled using standardized mean difference (SMD) or mean difference (MD), with random or fixed-effects models applied depending on heterogeneity. Results. Eleven studies involving 209 athletes were included. Compared with controls, a statistically significant increase in PPO was observed in a limited number of studies (MD = 97.38 W, 95% CI: 22.33 to 172.44, p < 0.05), along with significant changes in WBC (MD = 0.94 ×10⁹/L, 95% CI: 0.10 to 1.79, p < 0.05), and RDW (MD = 0.54%, 95% CI: 0.20 to 0.97, p < 0.05). No significant differences were found in CT, VO₂ peak, MPO, FI%, BLa, CK, CRP, SBP, DBP, HR, RPE, RBC, or Hb (all p > 0.05). Conclusion. The PPO finding should be interpreted with caution, as it was not consistently supported by other anaerobic indicators (MPO, FI%) and sensitivity analysis suggested influence from individual studies. Current evidence does not support long-term IPC as an effective intervention for enhancing overall athletic performance, accelerating recovery from muscle damage, or reducing perceived fatigue in athletes.
ER  -   
